270 related articles for article (PubMed ID: 33223512)
1. Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma.
Liu ZL; Zhu LL; Liu JH; Pu ZY; Ruan ZP; Chen J
Aging (Albany NY); 2020 Nov; 12(24):25172-25188. PubMed ID: 33223512
[TBL] [Abstract][Full Text] [Related]
2. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
[TBL] [Abstract][Full Text] [Related]
4. Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma.
Zhu C; Gu L; Liu Z; Li J; Yao M; Fang C
BMC Cancer; 2021 Jul; 21(1):836. PubMed ID: 34284746
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.
Huang M; He M; Guo Y; Li H; Shen S; Xie Y; Li X; Xiao H; Fang L; Li D; Peng B; Liang L; Yu J; Kuang M; Xu L; Peng S
Clin Cancer Res; 2020 Sep; 26(18):4947-4957. PubMed ID: 32527942
[TBL] [Abstract][Full Text] [Related]
6. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
Sia D; Jiao Y; Martinez-Quetglas I; Kuchuk O; Villacorta-Martin C; Castro de Moura M; Putra J; Camprecios G; Bassaganyas L; Akers N; Losic B; Waxman S; Thung SN; Mazzaferro V; Esteller M; Friedman SL; Schwartz M; Villanueva A; Llovet JM
Gastroenterology; 2017 Sep; 153(3):812-826. PubMed ID: 28624577
[TBL] [Abstract][Full Text] [Related]
7. Single sample scoring of hepatocellular carcinoma: A study based on data mining.
Zhu D; Wu ZH; Xu L; Yang DL
Int J Immunopathol Pharmacol; 2021; 35():20587384211018389. PubMed ID: 34053310
[TBL] [Abstract][Full Text] [Related]
8. Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma.
Li H; Liu H; Fu H; Li J; Xu L; Wang G; Wu H
Front Immunol; 2021; 12():648812. PubMed ID: 34122408
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MIAT correlates with immune infiltrates and drug reactions in hepatocellular carcinoma.
Peng L; Chen Y; Ou Q; Wang X; Tang N
Int Immunopharmacol; 2020 Dec; 89(Pt A):107071. PubMed ID: 33221703
[TBL] [Abstract][Full Text] [Related]
10. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas.
Castven D; Fischer M; Becker D; Heinrich S; Andersen JB; Strand D; Sprinzl MF; Strand S; Czauderna C; Heilmann-Heimbach S; Roessler S; Weinmann A; Wörns MA; Thorgeirsson SS; Galle PR; Matter MS; Lang H; Marquardt JU
Oncotarget; 2017 Jul; 8(30):48688-48700. PubMed ID: 28415775
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Mo Z; Liu D; Rong D; Zhang S
Front Immunol; 2021; 12():611058. PubMed ID: 33679749
[No Abstract] [Full Text] [Related]
12. Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling.
Wang H; Zhang C; Chi H; Meng Z
Int J Oncol; 2018 Jun; 52(6):2051-2060. PubMed ID: 29620259
[TBL] [Abstract][Full Text] [Related]
13. Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.
Cao D; Chen MK; Zhang QF; Zhou YF; Zhang MY; Mai SJ; Zhang YJ; Chen MS; Li XX; Wang HY
Aging (Albany NY); 2020 Jun; 12(12):12187-12205. PubMed ID: 32544882
[TBL] [Abstract][Full Text] [Related]
14. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
16. Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
Vizio B; Bosco O; David E; Caviglia GP; Abate ML; Schiavello M; Pucci A; Smedile A; Paraluppi G; Romagnoli R; Lupia E; Bellone G; Montrucchio G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673041
[TBL] [Abstract][Full Text] [Related]
17. Involvement of S100A6/S100A11 in T-Cell Immune Regulatory in HCC Revealed by Single Cell RNA-seq.
Zhou R; Pei B; Li X; Zhang X
Technol Cancer Res Treat; 2024; 23():15330338241252610. PubMed ID: 38766816
[No Abstract] [Full Text] [Related]
18. VEGF Family Gene Expression as Prognostic Biomarkers for Alzheimer's Disease and Primary Liver Cancer.
Xu K; Wu CL; Wang ZX; Wang HJ; Yin FJ; Li WD; Liu CC; Fan HN
Comput Math Methods Med; 2021; 2021():3422393. PubMed ID: 34845413
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
[TBL] [Abstract][Full Text] [Related]
20. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
Chen H; Li Y; Xiao SY; Guo J
BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
